This NDC is on FDA's drug shortage list (posted Mar 23, 2018)
Reported reason: Delay in shipping of the drug
Product Information
KETOROLAC 30 MG/ML VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $1.0448 per ML under NDC 63323016201. Its NADAC has been published 625 times since Nov 28, 2013.
FDA first approved this application on Jan 11, 2002. Its Orange Book therapeutic-equivalence code is AP.
Strength
30 mg/mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323016201
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Effective Date
8/19/2026
Active Ingredients
KETOROLAC TROMETHAMINEApproval Type
Generic (ANDA)
FDA Application
ANDA075784FDA Approved
1/11/2002
TE Code
AP
On Market Since
10/18/2000
Pharmacological Classes
Price Statistics
The NADAC for KETOROLAC 30 MG/ML VIAL has been published 625 times since Nov 28, 2013, and over the history we have for it it has risen 32.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0448 per ML |
|---|---|
| All-time high | $4.4589 (Nov 16, 2016) |
| All-time low | $0.6711 (Aug 20, 2014) |
| 52-week high | $1.1337 |
| 52-week low | $0.7047 |
| Median price | $1.4083 |
| Average price | $1.6481 |
| Largest weekly change | +94.7% (Aug 17, 2016) |
| Weeks tracked | 625 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 52% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KETOROLAC 30 MG/ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for KETOROLAC 30 MG/ML VIAL, manufactured by Fresenius Kabi USA, LLC, is $1.0448 per ML (NDC 63323016201), effective Aug 19, 2026.
How has the price of KETOROLAC 30 MG/ML VIAL changed over time?
Over the history we have for it, the NADAC for KETOROLAC 30 MG/ML VIAL has risen 32.4%. It has been tracked across 625 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for KETOROLAC 30 MG/ML VIAL?
Since Nov 28, 2013, the NADAC for KETOROLAC 30 MG/ML VIAL has ranged from a low of $0.6711 (Aug 20, 2014) to a high of $4.4589 (Nov 16, 2016), with a median of $1.4083 per ML.
Are there cheaper alternatives to KETOROLAC 30 MG/ML VIAL?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, KETOROLAC 60 MG/2 ML VIAL, is $0.4980 per ML — about 52% below KETOROLAC 30 MG/ML VIAL.
Who manufactures KETOROLAC 30 MG/ML VIAL?
KETOROLAC 30 MG/ML VIAL (NDC 63323016201) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.
Is KETOROLAC 30 MG/ML VIAL in shortage?
Yes — NDC 63323016201 is currently listed in FDA's drug shortage database (posted Mar 23, 2018). Reported reason: Delay in shipping of the drug.